| Date | Name | Symbol | Type | Security | Shares | Price | Value | Ownership | Reported |
| 04/03/2023 | Viking Therapeutics, Inc. | VKTX | Sale | Common Stock, par value $0.00001 per share | 30.9k | $18.00 | $556.4k | | 03/30/2023 |
| 04/03/2023 | Viking Therapeutics, Inc. | VKTX | Grant | Common Stock, par value $0.00001 per share | 56.7k | $0.00 | $0 | | 03/30/2023 |
| 04/03/2023 | Viking Therapeutics, Inc. | VKTX | Payment of Exercise | Common Stock, par value $0.00001 per share | 55.2k | $17.57 | $969.3k | | 03/30/2023 |
| 04/03/2023 | Viking Therapeutics, Inc. | VKTX | Exercise | Stock Option (right to buy) | 30.9k | $7.77 | $240.2k | | 03/30/2023 |
| 03/30/2023 | Viking Therapeutics, Inc. | VKTX | Sale | Common Stock, par value $0.00001 per share | 131k | $17.00 | $2.2M | | 03/30/2023 |
| 03/30/2023 | Viking Therapeutics, Inc. | VKTX | Exercise | Stock Option (right to buy) | 32k | $8.52 | $272.6k | | 03/30/2023 |
| 03/30/2023 | Viking Therapeutics, Inc. | VKTX | Exercise | Stock Option (right to buy) | 42k | $7.69 | $323k | | 03/30/2023 |
| 03/30/2023 | Viking Therapeutics, Inc. | VKTX | Exercise | Stock Option (right to buy) | 12.2k | $4.65 | $57k | | 03/30/2023 |
| 03/30/2023 | Viking Therapeutics, Inc. | VKTX | Exercise | Stock Option (right to buy) | 7.5k | $4.12 | $30.9k | | 03/30/2023 |
| 01/04/2023 | Viking Therapeutics, Inc. | VKTX | Payment of Exercise | Common Stock, par value $0.00001 per share | 20.7k | $8.42 | $174.4k | | 12/30/2022 |
| 01/03/2023 | Viking Therapeutics, Inc. | VKTX | Grant | Stock Option (Right to Buy) | 204k | $8.52 | $1.7M | | 12/30/2022 |
| 01/03/2023 | Viking Therapeutics, Inc. | VKTX | Grant | Common Stock, par value $0.00001 per share | 90.7k | $0.00 | $0 | | 12/30/2022 |
| 01/03/2023 | Viking Therapeutics, Inc. | VKTX | Payment of Exercise | Common Stock, par value $0.00001 per share | 23.9k | $8.52 | $203.9k | | 12/30/2022 |
| 12/30/2022 | Viking Therapeutics, Inc. | VKTX | Grant | Common Stock, par value $0.00001 per share | 20.2k | $0.00 | $0 | | 12/30/2022 |
| 12/30/2022 | Viking Therapeutics, Inc. | VKTX | Payment of Exercise | Common Stock, par value $0.00001 per share | 19.7k | $9.40 | $185.2k | | 12/30/2022 |
| 01/04/2022 | Viking Therapeutics, Inc. | VKTX | Payment of Exercise | Common Stock, par value $0.00001 per share | 8.8k | $4.62 | $40.8k | | 01/03/2022 |
| 01/03/2022 | Viking Therapeutics, Inc. | VKTX | Grant | Stock Option (Right to Buy) | 120k | $4.88 | $585.6k | | 01/03/2022 |
| 01/03/2022 | Viking Therapeutics, Inc. | VKTX | Payment of Exercise | Common Stock, par value $0.00001 per share | 3.1k | $4.88 | $15.1k | | 01/03/2022 |
| 01/03/2022 | Viking Therapeutics, Inc. | VKTX | Grant | Common Stock, par value $0.00001 per share | 53.3k | $0.00 | $0 | | 01/03/2022 |
| 09/28/2021 | Viking Therapeutics, Inc. | VKTX | Grant | Common Stock, par value $0.00001 per share | 6.7k | $0.00 | $0 | | 09/28/2021 |
| 09/28/2021 | Viking Therapeutics, Inc. | VKTX | Payment of Exercise | Common Stock, par value $0.00001 per share | 2.3k | $6.50 | $15k | | 09/28/2021 |
| 01/19/2021 | Viking Therapeutics, Inc. | VKTX | Payment of Exercise | Common Stock, par value $0.00001 per share | 808 | $6.68 | $5.4k | | 01/19/2021 |